Finnzymes, Genovis Sign US Distribution Pact | GenomeWeb

NEW YORK (GenomeWeb News) — Swedish biotech company Genovis said today that Finnzymes will take over US logistical operations and handle some promotions for Genovis products in the US.

Genovis offers RNAi, transfection, imaging, and antibody engineering products to biotechnology companies and academic researchers. Finnzymes develops PCR, quantitative real-time PCR, transposon, and RNA technologies, and it offers PCR instruments, reaction vessels, and DNA polymerases.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.